Natco launches Rs 1,290 semaglutide in India, undercuts diabetes drug prices - The Economic Times

Natco launches Rs 1,290 semaglutide in India, undercuts diabetes drug prices  The Economic TimesOzempic, Wegovy: India's cheap weight-loss drugs could reshape global obesity fight  BBCSemaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?  NDTVTsunami of weight-loss drugs to take over India today  India TodayOzempic Is About to Go Generic in India, China and Canada  The New York Times